RecruitingNCT07175350

Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study

Valutazione Della "Financial Toxicity" Nei Pazienti Sottoposti a Radioterapia: Uno Studio Multicentrico Italiano Promosso da yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica)


Sponsor

Valerio Nardone

Enrollment

1,000 participants

Start Date

Sep 6, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Non- profit, multicenter, prospective, observational study. The study aims to assess financial toxicity (FT) in patients undergoing radiotherapy for oncological diseases, assessed with a validated questionnaire (Patient Reported Outcome for Fighting FInancial Toxicity-PROFFIT- questionnaire).


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients older than 18 years of age.
  • Histological diagnosis of malignancy for which the patient requires radiotherapy treatment.

Exclusion Criteria1

  • Patient refusal to complete the questionnaire.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPROFFIT

The PROFFIT questionnaire is a PRO instrument composed by 16 items encompassing all the major life domains where FT can be expressed and is formed by two type of items: (1) outcome (items 1-7) and (2) determinants (items 8-16); EORTC QLQ-C30 questionnaire is a 30-item questionnaire that measures health-related quality of life (HRQOL) in cancer patients ; PRO-CTCAE is a short list of 43 symptoms relevant for ovarian cancer


Locations(7)

Radioterapia Oncologica - Ospedale Mons. Dimiccoli

Barletta, Italy

Unità di Radioterapia - Responsible Research Hospital

Campobasso, Italy

Radioterapia oncologica - Ospedale "Vito Fazzi" -

Lecce, Italy

AOU "L. Vanvitelli" - UOC Radioterapia

Naples, Italy

.C. Radioterapia - INT G. Pascale

Naples, Italy

Radioterapia Oncologica, IRCCS-CROB

Potenza, Italy

UOC Radioterapia - Fondazione Policlinico A. Gemelli

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07175350


Related Trials